D. Cohen

发表

Correction by factor VIII of the impaired platelet adhesion to subendothelium in von Willebrand disease.

H. Weiss, H. Baumgartner, V. Turitto, 1978, Blood.

Bacterial lipopolysaccharides prime macrophages for enhanced release of arachidonic acid metabolites

A. Aderem, S. Wright, Z. Cohn, 1986, The Journal of experimental medicine.

Protective effects of CGS 30440, a combined angiotensin-converting enzyme inhibitor and neutral endopeptidase inhibitor, in a model of chronic renal failure.

R. Dotson, J. Mathis, D. Cohen, 1998, Journal of cardiovascular pharmacology.

CGS 22652: A New Potent Thromboxane A2 Receptor Antagonist with Selective Thromboxane A2 Synthase Inhibitory Properties

R. Lappe, D. McMartin, P. Zane, 1992 .

Thromboxane receptor antagonism combined with thromboxane synthase inhibition. 4. 8-[[(4-Chlorophenyl)sulfonyl]amino]-4-(3-(3-pyridinyl) propyl)octanoic acid and analogs.

S. Bhagwat, W. Lee, R. Dotson, 1992, Journal of medicinal chemistry.

Thromboxane receptor antagonism combined with thromboxane synthase inhibition. 7. pyridinylalkyl-substituted arylsulfonylamino arylalkanoic acids.

S. Bhagwat, W. Lee, J. Mathis, 1992 .

Thromboxane receptor antagonism combined with thromboxane synthase inhibition. 2. Synthesis and biological activity of 8-(benzenesulfonamido)-7-(3-pyridinyl)octaonic acid and related compounds.

W. Lee, D. Cohen, A. Main, 1992, Journal of Medicinal Chemistry.

Beneficial effects of combined thromboxane synthase inhibition/receptor blockade with CGS 22652 in a canine model of coronary thrombosis.

R. Webb, R. Dotson, J. Mathis, 1993, European journal of pharmacology.

CGS 15435A, a thromboxane synthetase inhibitor with an extended duration of action: a comparison with dazoxiben.

E. F. Smith, E. Ku, D. Cohen, 1987, European journal of pharmacology.

CGS 30440 : A Dual Inhibitor of Angiotensin-Converting Enzyme and Neutral Endopeptidase 24

R. Webb, P. Zane, C. Fink, 1999 .

Aggregation, Release and Desensitization Induced in Platelets from Five Species by Platelet Activating Factor (PAF)

D. Cargill, D. Cohen, R. Levin, 1983, Thrombosis and Haemostasis.

Platelet Activating Factor (PAF)-Induced Aggregation And Release Responses In Vitro In Three Species

R. Saunders, D. Cargill, D. Cohen, 1981, Thrombosis and Haemostasis.

Thromboxane receptor antagonism combined with thromboxane synthase inhibition. 6. 4-substituted 3-pyridinylalkanoic acids.

S. Bhagwat, S. S. Shetty, W. Lee, 1992 .